Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 7/20 | 0.48 |
| ▸ | ADRA2B | P18089 | 3/20 | 0.48 |
| ▸ | ADRA2C | P18825 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | CASP1 | P29466 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10105579 | 0.93 | ADRA2A (0.46) | MAPTADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL526383 | 0.88 | MAPT (0.58) | MAPTADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL11616572 | 0.87 | TSHR (0.67) | MAPTADRA2AADRA2BADRA2CLMNA | |
| Ammonia Solution, Strong SCHEMBL28483632 | 0.85 | MAPT (0.56) | MAPTADRA2AADRA2BADRA2CLMNA | |
| Ammonia Solution, Strong SCHEMBL28486254 | 0.85 | MAPT (0.56) | MAPTADRA2AADRA2BADRA2CLMNA | |
| Hydrochloric Acid SCHEMBL9181167 | 0.85 | MAPT (0.56) | MAPTADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL11699237 | 0.83 | CA12 (0.52) | MAPTLMNATSHRALDH1A1RECQL | |
| SCHEMBL11747257 | 0.82 | HCAR3 (0.49) | MAPTLMNATSHRALDH1A1CA1 | |
| SCHEMBL1644806 | 0.81 | HPGD (0.50) | MAPTADRA2AADRA2BADRA2CLMNA | |
| SCHEMBL28219541 | 0.81 | MAPT (0.48) | MAPTADRA2AADRA2BADRA2CLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023028524-A1 | NEW ANTIDEGRADANTS BASED ON FATTY ACIDS OR DERIVATIVES FUNCTIONALIZED WITH PHENYLENEDIAMINES | FLEXSYS AMERICA L.P. (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-3483149-B1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | YUHAN CORP (KR) | 2021-01-13 | — | — | EP | disclosed |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | YUHAN CORPORATION (KR) | 2019-08-20 | — | — | US | disclosed |
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | YUHAN CORPORATION (KR) | 2019-05-16 | — | — | US | disclosed |
| EP-3483149-A1 | BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Yuhan Corporation (KR) | 2019-05-15 | — | — | EP | disclosed |
| EP-2877517-B1 | PROCESS FOR FORMING AN ARAMID COPOLYMER | DU PONT (US) | 2017-01-04 | — | — | EP | disclosed |
| US-9155738-B2 | Compounds for use in treatment of mucostitis | CELLCEUTIX CORPORATION (US) | 2015-10-13 | — | — | US | disclosed |
| US-20150094294-A1 | COMPOUNDS AND METHODS FOR TREATING MALARIA | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2015-04-02 | — | — | US | disclosed |
| US-20140364364-A1 | COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | INNOVATION PHARMACEUTICALS INC. | 2014-12-11 | — | — | US | disclosed |
| US-8865875-B2 | Site-specific attachment of drugs or other agents to engineered antibodies with C-terminal extensions | MEDAREX, L.L.C. (US) | 2014-10-21 | — | — | US | disclosed |
| US-8268970-B2 | Human antibodies that bind mesothelin, and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-09-18 | — | — | US | disclosed |
| US-20110280891-A1 | SITE-SPECIFIC ATTACHMENT OF DRUGS OR OTHER AGENTS TO ENGINEERED ANTIBODIES WITH C-TERMINAL EXTENSIONS | E. R. SQUIBB & SONS, L.L.C. | 2011-11-17 | — | — | US | disclosed |
| US-20110262448-A1 | HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2011-10-27 | — | — | US | disclosed |
| US-20100143368-A1 | Human Antibodies That Bind Cd22 And Uses Thereof | E. R. SQUIBB & SONS, L.L.C. | 2010-06-10 | — | — | US | disclosed |
| US-20080279868-A1 | Antibody-Drug Conjugates and Methods of Use | MEDAREX, INC. (US) | 2008-11-13 | — | — | US | disclosed |
| US-6613818-B1 | Composition for back coating film of mirror formed on metallic protective film, comprising vehicle containing synthetic resin, salt formed by neutralization of acid with base containing metal having greater ionization tendency, and base | CENTRAL GLASS COMPANY, LIMITED (JP) | 2003-09-02 | — | — | US | disclosed |
| EP-0089101-A2 | Direct positive image-forming process | KONICA CORPORATION (JP) | 1983-09-21 | — | — | EP | disclosed |
| US-4088587-A | ANTIOXIDANT AND PHOSPHORUS-CONTAINING COMPOSITION | CHEVRON RESEARCH COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-4032462-A | AN ANTIOXIDANT AND AN ORGANO-ANTIMONY COMPOUND | CHEVRON RESEARCH COMPANY (US) | 1977-06-28 | — | — | US | disclosed |
| US-3992307-A | BIS-PHOSPHORAMIDE | CHEVRON RESEARCH COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140364364-A1 | COMPOUNDS FOR USE IN TREATMENT OF MUCOSITIS | MUC1, FUT6, MMP8 | MAPT 4736/4885ADRA2A 4393/4885ADRA2B 4317/4885 |
| US-20150094294-A1 | COMPOUNDS AND METHODS FOR TREATING MALARIA | PC, CPS1, GLS2 | MAPT 1315/4885ADRA2A 3590/4885ADRA2B 4167/4885 |
| US-20110280891-A1 | SITE-SPECIFIC ATTACHMENT OF DRUGS OR OTHER AGENTS TO ENGINEERED ANTIBODIES WITH C-TERMINAL EXTENSIONS | FCGR2A, FCGR3B, FCGRT | MAPT 2327/4885ADRA2A 2551/4885ADRA2B 2820/4885 |
| US-20110262448-A1 | HUMAN ANTIBODIES THAT BIND MESOTHELIN, AND USES THEREOF | EPCAM, CD44, MUC1 | MAPT 3002/4885ADRA2A 4610/4885ADRA2B 4583/4885 |
| US-20190142809-A1 | Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same | ILK, SBDS, BDKRB1 | MAPT 2062/4885ADRA2A 3691/4885ADRA2B 2723/4885 |
| US-10383859-B2 | Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same | ILK, SBDS, BDKRB1 | MAPT 2062/4885ADRA2A 3691/4885ADRA2B 2723/4885 |
| US-20100143368-A1 | Human Antibodies That Bind Cd22 And Uses Thereof | CD2BP2, CD22, CD2 | MAPT 3906/4885ADRA2A 2894/4885ADRA2B 3044/4885 |
| US-20080279868-A1 | Antibody-Drug Conjugates and Methods of Use | CD47, ANTXR2, CD2BP2 | MAPT 2234/4885ADRA2A 3856/4885ADRA2B 3775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.